Affiliations: [a] Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Gazi University, Ankara, Turkey | [b] Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium | [c] Faculty of Medicine, Department of Neurology, Gazi University, Ankara, Turkey
Correspondence:
[*]
Address for correspondence: Deniz Bayraktar, PT. Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Gazi University, Emniyet Mahallesi, Muammer Yasar Bostanci Cad. No:16 Besevler/Ankara, 06500, Turkey. Tel.: +90 3122162629; Fax: +90 3122162636; E-mail: ptdenislav@yahoo.com
Abstract: Background:Multiple Sclerosis (MS) patients are often referred to aquatic physical therapy, but unfortunately, researches on the effects of aquatic therapy in MS patients are limited. Objective:The purpose of this study was to investigate the effects of Ai-Chi on balance, functional mobility, strength and fatigue in ambulatory patients with MS. Methods:Twenty-three ambulatory female patients were divided into two groups as experimental (n = 15) or control (n = 8) for an 8-week treatment program. The experimental group underwent Ai-Chi exercises in a swimming pool and the control group performed active arm and leg exercises combined with abdominal breathing exercises at home. Static standing balance was measured with duration of one-leg stance, functional mobility was evaluated with Timed-up and Go test and 6 minute walk test, upper and lower muscle strength was assessed with hand-held dynamometer and fatigue was evaluated with Fatigue Severity Scale. Results:Improvements were observed in static standing balance, functional mobility, upper and lower extremity muscle strength and fatigue in the Ai-Chi group (p < 0.05), but no significant differences in any outcome measures were observed in the control group (p > 0.05) after the intervention. Conclusions:According to these findings Ai-Chi may improve balance, functional mobility, upper and lower extremity muscle strength and fatigue in patients with MS.
